Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Anika Therapeutics buy Barrington Research

Start price
€18.10
14.08.23 / 50%
Target price
-
14.08.24
Performance (%)
25.97%
End price
€22.80
15.08.24
Summary
This prediction ended on 15.08.24 with a price of €22.80. The prediction had a final performance of 25.97%. Barrington_Research has a follow-up prediction for Anika Therapeutics where he still thinks Anika Therapeutics is a Buy. Barrington_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Anika Therapeutics 2.727% 2.727% 26.966%
iShares Core DAX® -1.114% 3.430% 25.966%
iShares Nasdaq 100 1.816% 6.911% 30.390%
iShares Nikkei 225® 2.113% 5.501% 23.404%
iShares S&P 500 2.038% 5.327% 30.881%

Comments by Barrington_Research for this prediction

In the thread Anika Therapeutics diskutieren

Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at Barrington Research from a "market perform" rating to an "outperform" rating.
Ratings data for ANIK provided by MarketBeat

In the thread Trading Anika Therapeutics
Prediction Buy
Perf. (%) 25.97%
Target price
Change
Ends at 14.08.24

Die von Barrington_Research gewählte maximale Laufzeit wurde überschritten

Current prediction by Barrington_Research for Anika Therapeutics

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€19.70
03.11.23
€26.08
03.11.24
14.72%
03.10.24

Stopped prediction by Barrington_Research for Anika Therapeutics

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€23.40
09.05.24
€34.32
09.05.25
-3.42%
03.10.24

buy
Anika Therapeutics

Start price
Target price
Perf. (%)
€20.60
03.01.24
€26.58
03.01.25
9.71%
03.10.24